Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
14 resultat
Bis(arylmethylidene)acetone compound, anti-cancer agent, carcinogenesis-preventive agent, inhibitor of expression of Ki-Ras, ErbB2, c-Myc and Cycline D1, .beta.-catenin-degrading agent, and p53 expression enhancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention relates to a novel pharmacological agent that is used for inhibiting the growth of various cancer cells and for preventing carcinogenesis. The present invention also relates to novel bis(arylmethylidene)-acetones and salts thereof.
BACKGROUND ART
Curcumin
Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority of Taiwanese Application No. 093114351, filed on May 21, 2004.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to an acetone-extracted product obtained from gamboge resin and compounds further
Angelicae sinensis extracts useful for treatment of cancers
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The invention mainly relates to a new use of an acetone extract, chloroform extract or hexane extract of Angelicae sinensis and the active components purified therefrom in the treatment of cancers.
Cancers are abnormal cell proliferations that result from the accumulation
Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the National Stage of PCT/RU2013/000568 filed on Jul. 19, 2013, which claims priority under 35 U.S.C. .sctn.119 of Russian Application No. 2012144002 filed on Oct. 16, 2012, the disclosures of which are incorporated by reference. The
Compound obtained from gamboge resin, and medical uses of the same
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority of Taiwanese Application No. 099119107, filed on Jun. 11, 2010.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to seventeen new compounds obtained from an acetone-extracted product of gamboge resin.
Photosensitizer and method for production thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
DESCRIPTION
The invention concerns the sphere of medicine, particularly the sphere of photodynamic therapy (PDT) with the use of biologically active compounds.
Photosensitizers (PS) are used as therapeutic agents at PDT and as fluorescent labels at photodynamic diagnostics (PDD).
Mono-L-aspartil
Photosensitizer and method for production thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The invention concerns the sphere of medicine, particularly the sphere of photodynamic therapy (PDT) with the use of biologically active compounds.
Photosensitizers (PS) are used as therapeutic agents at PDT and as fluorescent labels at photodynamic diagnostics (PDD).
Mono-L-aspartil chlorin e.sub.6
Inhibitory effect of synthetic and natural colorants on carcinogenesis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The field of the invention relates to use of food colorants in the treatment or prevention of cancer. More particularly, the invention relates to use of safe, nontoxic food colorants to inhibit carcinogenesis. The food colorants may be natural pigments extracted from a plant
Topical compositions and methods for treating pain
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
II. FIELD OF THE INVENTION
The present invention is directed to a topical composition for treating pain in mammals. Specifically, the present invention comprises a safe and effective amount of acetone, a salicylate-based compound, an emollient and one or more compounds which can function as an
Intratumoral use of dinitrochorobenzene: composition and use of injections including particular applications
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
This invention pertains to the treatment of benign and malignant tumors by injections. Dinitrochlorobenzene (or DNCB) and other dinitrohalogenated compounds are chemicals which, when applied to the skin, act as a haptens with associated skin proteins and elicit
Process for making metabolites of lycopene
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention is concerned with a multi-stage process for the manufacture of an oxidative metabolite of the carotenoid lycopene as well a novel intermediates produced in the manufacturing process.
BACKGROUND OF THE INVENTION
As is known, carotenoids, inter alia,
Method for extracting high content of chlorogenic acids from green coffee beans
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATION
This U.S. application claims priority under 35 U.S.C. 371 to, and is a U.S. National Phase application of, the International Patent Application No. PCT/IN2015/000236, filed 10 Jun. 2015, which claims priority from Indian Patent Application No. 1614/DEL/2014
Mixture having antitumor activities
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
SUMMARY OF THE INVENTION
Tice.RTM. substrain BCG is used clinically as an immunotherapeutic agent against superficial bladder cancer. A boiling water extract of this BCG showed antitumor activity against a murine S180 sarcoma model and was fractionated into three fractions, A, B and C, by the use of
Antitumor substance
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a new antitumor substance and, in particular, relates to a new substance having antitumor activity against certain types of tumors and containing protein, which substance is obtained from an epidermal portion of rice.
2.
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
